Related Experiment Video
Updated: Jun 24, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Benign lesions accompanied by intractable epilepsy in children
George A Alexiou1, Maria Varela, George Sfakianos
1Department of Neurosurgery, Children's Hospital Agia Sofia, Athens, Greece. alexiougrg@yahoo.gr
Insights
Pediatric epilepsy surgery offers a safe and effective treatment for children with intractable epilepsy, particularly those with brain abnormalities. This study found that 79% of young patients became seizure-free after surgery, with no lasting complications.
Area of Science:
- Pediatric Neurosurgery
- Epileptology
- Neuropathology
Background:
- Intractable epilepsy in children often necessitates surgical intervention, especially when structural brain abnormalities are present.
- Epilepsy surgery is considered a viable treatment option for pediatric patients with drug-resistant seizures.
Purpose of the Study:
- To evaluate the safety and efficacy of epilepsy surgery in children with intractable epilepsy.
- To analyze the types of brain lesions and their locations in pediatric epilepsy surgery cases.
- To determine seizure outcomes and complication rates following surgical treatment.
Main Methods:
- A cohort of 24 children with intractable epilepsy underwent surgical resection of brain lesions.
- Histopathological examination identified various lesions including ganglioglioma, dysembryoplastic neuroepithelial tumors, glioma, cortical dysplasia, and cavernous malformations.
- Patients were followed up for a mean of 4.4 years to assess seizure status and neurological outcomes.
Main Results:
- The majority of lesions (18/24) were located in the temporal lobe.
- Seventy-nine percent (19/24) of the pediatric patients achieved seizure freedom post-surgery.
- No permanent neurological deficits or deaths were reported, indicating a safe surgical profile.
Conclusions:
- Epilepsy surgery is a safe and effective procedure for treating intractable focal epilepsy in children.
- Surgical intervention can lead to significant seizure reduction and improved quality of life in pediatric patients.
- Early surgical consideration for children with specific brain abnormalities and intractable epilepsy is warranted.
Abstract:
Epilepsy surgery has been proposed as a safe alternative treatment for intractable epilepsy in children, especially for patients with structural brain abnormalities. We studied 24 consecutive children who underwent surgery for intractable epilepsy. There were 12 males and 12 females. The mean age was 6.5 years. The seizures' duration ranged from 6 months to 2 years. The histopathological examination of the resected lesions revealed in 12 cases the presence of a ganglioglioma, in 7 cases dysembryoplastic neuroepithelial tumor, in 1 case a low grade glioma, in 2 cases cortical dysplasia, and in 2 cases cavernous malformations. In 18 cases, the lesions were located in the temporal lobe and in 6 cases the lesions were extratemporal. After a mean follow-up period of 4.4 years, 79% (19/24) of patients were seizure free. There were no permanent neurological deficits or deaths. Surgery for focal epilepsy in children is a safe procedure with favorable results.
Related Concept Videos
Epilepsy ll: Types
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures l: Introduction
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
